Extended-Release Tofacitinib Monotherapy Effectively Treats Severe RA After MTX Withdrawal
The ORAL Shift study enrolled 694 RA patients who were inadequate responders to methotrexate alone.
All articles by Diana Ernst, RPh
Febuxostat Labeling Updated With Boxed Warning After Review of Safety Data
The prescribing information for Uloric (febuxostat; Takeda) is being updated to include a Boxed Warning regarding an increased risk of cardiovascular (CV) death and all-cause mortality in patients treated with the gout drug.
Next post in Gout
